External medication packaging
Latest Pfizer Inc. Patents:
- Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-mides
- METHODS AND DOSING REGIMENS COMPRISING A CDK2 INHIBITOR FOR THE TREATMENT OF CANCER
- MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF
- Solid Forms of 2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine Salt
- Pyrido[4,3-d]pyrimidine compounds
The broken lines in the drawings represent unclaimed subject matter and form no part of the claim.
The evenly broken lines are shown for the purpose of illustrating environmental subject matter of exemplary blister packages and form no part of the claimed design.
The heavy oval dashed lines shown on the top surface of
Claims
The ornamental design for an external medication packaging, as shown and described.
D503614 | April 5, 2005 | Sax |
D707552 | June 24, 2014 | Ahn |
D746677 | January 5, 2016 | Candelaria |
D756237 | May 17, 2016 | Kruse |
D842692 | March 12, 2019 | Breen |
D843850 | March 26, 2019 | LoPrete |
D874925 | February 11, 2020 | Ronge |
D904879 | December 15, 2020 | Lee |
202009007171 | September 2009 | DE |
2841874 | January 2004 | FR |
216294 | January 2023 | RU |
- What is Paxlovid? How it treats COVID and who should take it—YouTube. Date posted: Aug. 2, 2022. Site visited: Apr. 25, 2023. Available online: https://www.youtube.com/watch?v=-VsV2pE5e3U (Year: 2022).
- “The Perfect Medicalpackaging? Clear, Simple Andtrusty!”, in Packly Blog. Date published: Aug. 4, 2017. Site visited: Apr. 25, 2023. Available online: https://blog.pack.ly/en/medical-packaging-clear-design/ (Year: 2017).
- “China approves use of Pfi zer's COVID drug Paxlovid,” published in Reuters.com. Date published: Feb. 14, 2022. Site visited: Apr. 25, 2023. Available online: https://www.reuters.com/business/healthcare-pharmaceuticals/china-gives-conditional-approval-pfizers-covid-drug-paxlovid-2022-02-12/ (Year: 2022).
Type: Grant
Filed: Dec 20, 2021
Date of Patent: Feb 13, 2024
Assignee: Pfizer Inc. (New York, NY)
Inventors: Merle Lee (Brentwood, NY), Anthony Mazza (Hasbrouck Heights, NJ), Andrew Ruocco (Morristown, NJ), Kari Peterson (Verona, WI), Hetal Naik (Walton Oaks)
Primary Examiner: Catherine S Posthauer
Assistant Examiner: Joan E. Diehl
Application Number: 29/820,181